The Enforcement Reality: Why Most Nicotine Regulations Exist Only on Paper
The gap between nicotine regulation-on-the-books and regulation-in-practice is vast—and it's growing. Enforcement capacity has not kept pace with regulatory ambition. The result is a system that looks strict from a distance and is porous up close.
The FDA has issued thousands of warning letters to retailers selling unauthorized vaping products. The press releases announcing these letters describe them as 'enforcement actions' and characterize the agency's efforts as 'aggressive.' But walk into any convenience store in America and you'll find the same unauthorized products that were the subject of those warning letters—still on the shelves, still being sold, still generating revenue for the retailers and the manufacturers that the FDA's 'enforcement actions' were supposed to deter. **The gap between nicotine regulation-on-the-books and regulation-in-practice is vast—and it's growing. The FDA's enforcement capacity has not kept pace with its regulatory ambition. The result is a system that projects strength from a distance and reveals weakness up close.**
**The capacity gap is structural, not individual.** The FDA's Center for Tobacco Products has approximately 1,100 employees and a budget of roughly $700 million—adequate for regulating a traditional tobacco market of a few hundred products, but wildly inadequate for regulating a market of millions of vaping products sold through hundreds of thousands of retail outlets. The agency cannot inspect every retailer. It cannot seize every unauthorized product. It cannot, in any meaningful sense, enforce the regulatory framework it has created. **The enforcement gap is not a failure of effort. It's a failure of design—a regulatory system built for a market that no longer exists, applying rules that exceed the system's capacity to enforce them.**
**The consequences are corrosive.** When retailers observe that warning letters don't lead to meaningful consequences, the deterrent effect of regulation evaporates. When consumers observe that unauthorized products remain available despite regulatory pronouncements, the legitimacy of the regulatory system erodes. **A regulatory system that cannot enforce its own rules is a system that trains the regulated community to ignore it—and the training, once established, is difficult to reverse.**
**💬 Have you noticed products on store shelves that you know—or suspect—are not authorized by the FDA? Does the gap between what regulators say and what actually happens affect your trust in the regulatory system?**
